Andrews, Christina M.

The affordable care act transformation of substance use disorder treatment

Abraham, A. J., Andrews, C. M., Grogan, C. M., D’Aunno, T., Humphreys, K. N., Pollack, H. A., & Friedmann, P. D. (2017) · American Journal of Public Health

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 79

Medicaid benefits for addiction treatment expanded after implementation of the Affordable Care Act

Andrews, C. M., Grogan, C. M., Smith, B. T., Abraham, A. J., Pollack, H. A., Humphreys, K., Westlake, M. A., & Friedmann, P. D. (2018) · Health Affairs

Healthcare Policy and ManagementOpioid Use Disorder Treatment

Cited by 54

Impact of Medicaid restrictions on availability of buprenorphine in addiction treatment programs

Andrews, C. M., Abraham, A. J., Grogan, C. M., Westlake, M. A., Pollack, H. A., & Friedmann, P. D. (2019) · American Journal of Public Health

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 43

Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment Benefits: Study examines Medicaid managed care plans’ restrictions on substance use disorder treatment

Peterson, L. A., Andrews, C. M., Abraham, A. J., Westlake, M. A., & Grogan, C. M. (2024) · Health Affairs

Healthcare Policy and ManagementSubstance Abuse Treatment and Outcomes

Cited by 12

Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021

Shoulders, A., Andrews, C. M., Westlake, M. A., Abraham, A. J., & Grogan, C. M. (2023) · JAMA Health Forum

Opioid Use Disorder TreatmentHealthcare Policy and Management

Cited by 11